-+ 0.00%
-+ 0.00%
-+ 0.00%

Intensity Therapeutics FY2025 net loss narrows 28.66% to $(11.6) million; operating expenses drop 27.81% to $12.0 million

Reuters·03/27/2026 20:02:42

Please log in to view news